Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women

Inclusion Criteria: * Generally healthy, postmenopausal women aged 40 - 75 years inclusive * Intact uterus * Last natural menstrual cycle (without exogenous hormone therapy) completed at least 12 consecutive months before screening Exclusion Criteria: * A history or active presence of thrombophlebitis, thrombosis or thromboembolic disorders * A history or active presence of cerebrovascular accident, stroke, or transient ischemic attack * A history or active presence of malignancy, or treatment for malignancy, within the previous 10 years Additional criteria applies.